Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Scopolamine (DPI-386)
.
Show all posts
Showing posts with label
Scopolamine (DPI-386)
.
Show all posts
Thursday, August 8, 2024
Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults
›
Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced the...
›
Home
View web version
